Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Sensitive Tuberculosis”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07525427
What this trial is testing

Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis

Who this might be right for
Drug Susceptible Pulmonary Tuberculosis
Gates Medical Research Institute 150
Testing effectiveness (Phase 2)Study completedNCT02256696
What this trial is testing

Assessing PA-824 for Tuberculosis (the APT Trial)

Who this might be right for
Pulmonary Tuberculosis
Johns Hopkins University 157
Testing effectiveness (Phase 2)Study completedNCT02193776
What this trial is testing

To Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.

Who this might be right for
Tuberculosis
Global Alliance for TB Drug Development 240
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT06058299
What this trial is testing

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis

Who this might be right for
Pulmonary TBPulmonary TuberculosisDrug Sensitive Tuberculosis
Global Alliance for TB Drug Development 309
Testing effectiveness (Phase 2)Study completedNCT04044001
What this trial is testing

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Who this might be right for
Pulmonary TuberculosesOther Specified Pulmonary Tuberculosis
Michael Hoelscher 77
Testing effectiveness (Phase 2)Study completedNCT02381470
What this trial is testing

Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers

Who this might be right for
Pulmonary Tuberculosis
National University Hospital, Singapore 58
Testing effectiveness (Phase 2)UnknownNCT02968927
What this trial is testing

TB Host Directed Therapy

Who this might be right for
Tuberculosis
The Aurum Institute NPC 200
Not applicableLooking for participantsNCT05797649
What this trial is testing

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

Who this might be right for
Pleural EffusionHeart FailureMalignant Neoplasm+5 more
Chinese University of Hong Kong 120
Early research (Phase 1)Study completedNCT05526911
What this trial is testing

A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults

Who this might be right for
Pulmonary DiseaseTuberculosis, PulmonaryTuberculosis+4 more
Global Alliance for TB Drug Development 28
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Early research (Phase 1)Study completedNCT04493671
What this trial is testing

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults

Who this might be right for
Pulmonary DiseaseTuberculosis, PulmonaryTuberculosis+4 more
Global Alliance for TB Drug Development 137
Testing effectiveness (Phase 2)Study completedNCT03563599
What this trial is testing

Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)

Who this might be right for
Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB
Qurient Co., Ltd. 60
Large-scale testing (Phase 3)Looking for participantsNCT07209761
What this trial is testing

Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 532
Not applicableNot Yet RecruitingNCT06921278
What this trial is testing

Development of the Drug and Alcohol Respiratory Health Test

Who this might be right for
Respiratory DiseaseSubstance-Related DisordersCOPD+6 more
King's College London 260
Testing effectiveness (Phase 2)Study completedNCT01225640
What this trial is testing

PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay

Who this might be right for
Tuberculosis
Sequella, Inc. 59
Testing effectiveness (Phase 2)UnknownNCT05926466
What this trial is testing

BTZ-043 Dose Evaluation in Combination and Selection

Who this might be right for
Tuberculosis, PulmonaryOther Specified Pulmonary Tuberculosis
Michael Hoelscher 90
Testing effectiveness (Phase 2)Study completedNCT01498419
What this trial is testing

Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 207
Testing effectiveness (Phase 2)Study completedNCT02619994
What this trial is testing

Treatment Shortening of MDR-TB Using Existing and New Drugs

Who this might be right for
Tuberculosis, Multidrug-Resistant
Seoul National University Hospital 214
Testing effectiveness (Phase 2)Study completedNCT01241188
What this trial is testing

A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB)

Who this might be right for
Tuberculosis
Statens Serum Institut 253
Load More Results